Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Organovo Holdings Inc    ONVO

ORGANOVO HOLDINGS INC (ONVO)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/17/2018 09/18/2018 09/19/2018 09/20/2018 09/21/2018 Date
1.19(c) 1.2(c) 1.16(c) 1.19(c) 1.14(c) Last
637 856 451 103 562 478 343 994 1 586 008 Volume
-0.83% +0.84% -3.33% +2.59% -4.20% Change
More quotes
Financials (USD)
Sales 2019 3,93 M
EBIT 2019 -30,1 M
Net income 2019 -29,8 M
Finance 2019 38,1 M
Yield 2019 -
Sales 2020 5,42 M
EBIT 2020 -31,4 M
Net income 2020 -31,3 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales2019 24,7x
Capi. / Sales2020 24,9x
Capitalization 135 M
More Financials
Company
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications.It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be... 
More about the company
Surperformance© ratings of Organovo Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ORGANOVO HOLDINGS INC
08/15ORGANOVO HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/14Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GL
08/10ORGANOVO : Fiscal 1Q Earnings Snapshot
AQ
08/09ORGANOVO HOLDINGS, INC. : Results of Operations and Financial Condition, Financi..
AQ
08/09ORGANOVO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
08/09Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expa..
GL
08/09ORGANOVO HOLDINGS INC : Organovo Holdings, Inc. to Host Earnings Call
AC
08/01Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Off..
GL
07/27ORGANOVO HOLDINGS, INC. : Change in Directors or Principal Officers, Amendments ..
AQ
07/20Free Pre-Market Technical Recap on ResMed and Three Additional Healthcare Sto..
AC
More news
Sector news : Biotechnology & Medical Research - NEC
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug in First European Setback -..
DJ
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug for Some Patients Despite D..
DJ
09/19GILEAD SCIENCES : UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
RE
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans
DJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
09/14Organovo $ONVO Downgraded by Zacks Investment Research  
09/11Organovo $ONVO Cut to Sell at Zacks Investment Research  
09/08Brokerages Anticipate Organovo Holdings Inc $ONVO to Announce -$0.08 EPS  
09/06Get the latest news and updates for $JBGS $GGB $ONVO $MDCO $SUG automatically.. 
09/04Brokerages Set Organovo Holdings Inc $ONVO Price Target at $3.25  
More tweets
Qtime:34
News from SeekingAlpha
08/10PREMARKET LOSERS AS OF 9 : 05 am (8/10/2018) 
08/10Organovo Holdings Q1 revenues down 30% 
08/09Organovo Holdings, Inc. (ONVO) CEO Taylor Crouch on Q1 2019 Results - Earning.. 
08/09Organovo Holdings EPS in-line, misses on revenue 
08/01Actions And Reactions During Earnings Season - The Idea Guide 
Chart ORGANOVO HOLDINGS INC
Duration : Period :
Organovo Holdings Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ORGANOVO HOLDINGS INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 2,58 $
Spread / Average Target 117%
EPS Revisions
Managers
NameTitle
Taylor J. Crouch President, Chief Executive Officer & Director
Kirk D. Malloy Chairman
Craig S. Kussman Chief Financial Officer
Sharon Collins Presnell Chief Scientific Officer
Steven G. Hughes Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ORGANOVO HOLDINGS INC-14.93%135
CELLTRION, INC.--.--%33 388
IQVIA HOLDINGS INC30.32%25 763
LONZA GROUP18.80%24 291
INCYTE CORPORATION-29.69%14 156
SEATTLE GENETICS, INC.45.35%12 348